Get the app
NSE › Healthcare

Indraprastha Medical Corporation Limited (INDRAMEDCO)

NSE · Healthcare · Medical Care Facilities

₹330.20-1.06%
Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue
₹406 cr
Revenue YoY
+11.3%
Net profit
₹56 cr
Profit YoY
+8.5%
Net margin
13.8%

Key statistics

Market cap
₹3,060 cr
P/E
16.3
Forward P/E
9.1
P/B
3.94
Book value
₹88.77
EPS (TTM)
₹20.51
Dividend yield
1.19%
52-week high
₹616.15
52-week low
₹293.65
50-day MA
₹340.18
200-day MA
₹377.58
Beta
0.51

Analyst view

with an average price target of ₹550.00.

Shareholding

Promoters
51.00%
Institutions
4.16%

Largest named holders

HolderStake
Emedlife Insurance Broking Services1.70%
Citadel Research and Solutions1.29%
Investor Education and Protection Fund Authority Ministry of Corporate Affairs1.07%
Trust0.01%

Recent filings & reports

DocumentDate
Annual report FY2026
INDRAPRASTHA MEDICAL CORPORATION LIMITED – ANNUAL REPORT FY 2025-26 SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Market Capitalization: ₹3,413.44
2026-09-01
Quarterly results · Q1 FY27
INDRAPRASTHA MEDICAL CORPORATION LIMITED – SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Q1 FY2026-27 (Quarter ended 30 June 2026) Revenue from Op
2026-08-06
Quarterly results · Q4 FY26
DOCUMENT SUMMARY - INDRAPRASTHA APOLLO HOSPITALS I cannot provide the requested summary because the document excerpt provided contains only administr
2026-05-12
Quarterly results · Q3 FY26
INDRAPRASTHA MEDICAL CORPORATION LIMITED – DOCUMENT SUMMARY BUSINESS & SEGMENT HIGHLIGHTS • Board approved un-audited financial results for Q3 FY202
2026-02-03
Quarterly results · Q2 FY26
INDRAPRASTHA APOLLO HOSPITALS - DOCUMENT SUMMARY HEADLINE NUMBERS • Reporting Period: Quarter ended 30th September 2025 (Q2 FY2025-26) • Financial S
2025-11-01
Annual report FY2025
INDRAPRASTHA MEDICAL CORPORATION LIMITED – ANNUAL REPORT 2024-25 SUMMARY HEADLINE NUMBERS • Market Capitalisation (as of 31 March 2025): ₹3,529.41 C
2025-09-01
Quarterly results · Q1 FY26
INDRAPRASTHA MEDICAL CORPORATION LIMITED – Q1 FY2025-26 SUMMARY --- HEADLINE NUMBERS • Revenue from operations Q1 FY26: Rs 365.06 crore (vs Rs 347.
2025-08-06
Quarterly results2025-02-03

Readable in the app.

Corporate actions

ActionDetailDate
Dividend₹4 / share
ex-date Sep 18, 2026
2026-09-18

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Indraprastha Medical Corporation Limited — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Data updated 2026-11-07.